pegaspargase 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |

Stem definitionDrug idCAS RN
enzymes 5082 130167-69-0

Description:

MoleculeDescription

Synonyms:

  • pegaspargase
  • oncaspar
covalent attachment of PEG to enzyme produces active, stable complex; non-immunogenic; used in treatment of leukemia
  • Molecular weight:
  • Formula:
  • CLOGP:
  • LIPINSKI: None
  • HAC: None
  • HDO: None
  • TPSA:
  • ALOGS:
  • ROTB: None

Drug dosage:

None

ADMET properties:

None

Approvals:

DateAgencyCompanyOrphan
Feb. 1, 1994 FDA SIGMA TAU

FDA Adverse Event Reporting System (Female)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Febrile neutropenia 1082.16 28.58 484 10378 117965 63360195
Febrile bone marrow aplasia 920.42 28.58 220 10642 7105 63471055
Hypofibrinogenaemia 442.03 28.58 87 10775 1083 63477077
Hypertriglyceridaemia 296.99 28.58 87 10775 6172 63471988
Hyperbilirubinaemia 190.53 28.58 72 10790 11242 63466918
Blood culture positive 161.19 28.58 51 10811 4684 63473476
Neutropenia 152.58 28.58 168 10694 174837 63303323
Rhinovirus infection 134.59 28.58 44 10818 4485 63473675
Superior sagittal sinus thrombosis 121.47 28.58 28 10834 763 63477397
Sepsis 121.44 28.58 140 10722 152983 63325177
Pancreatitis 111.27 28.58 81 10781 48974 63429186
Human bocavirus infection 110.16 28.58 23 10839 390 63477770
Pyrexia 109.46 28.58 245 10617 470233 63007927
Bacterial infection 108.25 28.58 57 10805 19442 63458718
Hepatocellular injury 108.18 28.58 64 10798 27317 63450843
Posterior reversible encephalopathy syndrome 99.98 28.58 52 10810 17293 63460867
Drug ineffective 98.05 28.58 29 10833 1044736 62433424
Septic shock 95.41 28.58 84 10778 66545 63411615
Mucosal inflammation 91.97 28.58 71 10791 46857 63431303
Enterobacter infection 88.46 28.58 27 10835 2200 63475960
Venoocclusive liver disease 85.85 28.58 32 10830 4803 63473357
Mucormycosis 85.73 28.58 28 10834 2843 63475317
Pyomyositis 83.54 28.58 18 10844 357 63477803
Hyperglycaemia 81.28 28.58 63 10799 41804 63436356
Human herpesvirus 6 infection 80.92 28.58 27 10835 2930 63475230
Colitis 79.28 28.58 66 10796 48462 63429698
Lipase increased 78.86 28.58 37 10825 9863 63468297
Secondary immunodeficiency 77.97 28.58 22 10840 1361 63476799
Perineal necrosis 76.59 28.58 14 10848 113 63478047
Herpes simplex 75.56 28.58 34 10828 8237 63469923
Perineal infection 74.07 28.58 14 10848 138 63478022
Pneumatosis intestinalis 73.95 28.58 24 10838 2389 63475771
Blood fibrinogen decreased 73.67 28.58 19 10843 834 63477326
Gastroenteritis norovirus 73.39 28.58 23 10839 2045 63476115
Hypotension 71.19 28.58 149 10713 272455 63205705
Potentiating drug interaction 67.13 28.58 26 10836 4330 63473830
Bacteraemia 61.91 28.58 38 10824 17310 63460850
Fatigue 61.87 28.58 38 10824 887990 62590170
Pseudomonas test positive 61.40 28.58 16 10846 732 63477428
Venous thrombosis 60.74 28.58 25 10837 4877 63473283
Antithrombin III decreased 60.61 28.58 13 10849 252 63477908
Neurotoxicity 57.55 28.58 36 10826 16954 63461206
Thrombocytopenia 57.33 28.58 97 10765 151060 63327100
Antithrombin III 54.52 28.58 11 10851 156 63478004
Fusarium infection 53.90 28.58 14 10848 632 63477528
Tachycardia 53.22 28.58 82 10780 118074 63360086
Hypoalbuminaemia 53.00 28.58 30 10832 11775 63466385
Clostridium test positive 52.52 28.58 20 10842 3181 63474979
Blood bilirubin increased 51.49 28.58 46 10816 37094 63441066
Anaphylactic reaction 48.23 28.58 58 10804 66042 63412118
Pancytopenia 47.52 28.58 70 10792 96863 63381297
Human rhinovirus test positive 47.17 28.58 10 10852 183 63477977
Seizure 46.20 28.58 82 10780 132552 63345608
Transverse sinus thrombosis 46.11 28.58 12 10850 546 63477614
Bone marrow failure 46.09 28.58 39 10823 29251 63448909
Pulmonary haemorrhage 45.63 28.58 23 10839 7158 63471002
Cerebral venous thrombosis 45.31 28.58 16 10846 2058 63476102
Hepatic failure 45.19 28.58 42 10820 35614 63442546
Device related infection 44.95 28.58 35 10827 23357 63454803
Arthralgia 44.50 28.58 21 10841 569689 62908471
Alanine aminotransferase increased 43.91 28.58 70 10792 103700 63374460
Acute lymphocytic leukaemia recurrent 43.90 28.58 16 10846 2253 63475907
Respiratory distress 43.05 28.58 40 10822 33911 63444249
Pseudomonal sepsis 43.02 28.58 16 10846 2385 63475775
Blood lactic acid increased 43 28.58 22 10840 7064 63471096
Neuropathy peripheral 40.52 28.58 71 10791 113596 63364564
Clostridium difficile colitis 40.00 28.58 31 10831 20538 63457622
Cholestasis 39.89 28.58 36 10826 29398 63448762
Enteritis 39.76 28.58 22 10840 8264 63469896
Hyperlipidaemia 39.16 28.58 30 10832 19541 63458619
Neutrophil count decreased 38.72 28.58 48 10814 56358 63421802
Blood triglycerides increased 38.65 28.58 25 10837 12463 63465697
Drug intolerance 38.60 28.58 4 10858 308657 63169503
Pancreatitis acute 38.35 28.58 34 10828 27132 63451028
Escherichia test positive 35.92 28.58 14 10848 2370 63475790
Streptococcus test positive 35.86 28.58 12 10850 1313 63476847
Perirectal abscess 35.84 28.58 11 10851 912 63477248
Coagulopathy 35.74 28.58 29 10833 20515 63457645
Abdominal discomfort 35.73 28.58 6 10856 320879 63157281
Disseminated intravascular coagulation 35.51 28.58 28 10834 19023 63459137
Pain 35.44 28.58 45 10817 740583 62737577
Quadriparesis 34.45 28.58 13 10849 2016 63476144
Pruritus 33.74 28.58 10 10852 361443 63116717
Rhinocerebral mucormycosis 33.64 28.58 9 10853 456 63477704
Staphylococcal bacteraemia 33.07 28.58 17 10845 5513 63472647
Fall 32.92 28.58 13 10849 392321 63085839
Rash 32.46 28.58 29 10833 560842 62917318
Fungaemia 32.32 28.58 13 10849 2390 63475770
Staphylococcal sepsis 32.09 28.58 19 10843 8109 63470051
Enterovirus test positive 31.75 28.58 7 10855 155 63478005
Respiratory failure 31.69 28.58 60 10802 101798 63376362
Cerebral venous sinus thrombosis 31.20 28.58 12 10850 1960 63476200
Post lumbar puncture syndrome 31.14 28.58 9 10853 607 63477553
Weight increased 31.05 28.58 4 10858 260788 63217372
Hyperglycaemic hyperosmolar nonketotic syndrome 30.97 28.58 10 10852 979 63477181
Multiple organ dysfunction syndrome 30.75 28.58 43 10819 56709 63421451
Enterovirus infection 30.72 28.58 10 10852 1004 63477156
Ileus 30.40 28.58 23 10839 14702 63463458
Endophthalmitis 30.39 28.58 14 10848 3578 63474582
Enterocolitis 30.06 28.58 18 10844 7840 63470320
Pseudomonal bacteraemia 29.72 28.58 11 10851 1617 63476543
Escherichia bacteraemia 29.35 28.58 14 10848 3869 63474291
Pancreatitis necrotising 29.18 28.58 11 10851 1701 63476459
Cystitis bacterial 29.13 28.58 7 10855 229 63477931
Breakthrough pain 28.70 28.58 10 10852 1236 63476924

FDA Adverse Event Reporting System (Male)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Febrile neutropenia 951.98 22.62 627 13756 136222 34806326
Hypofibrinogenaemia 577.91 22.62 135 14248 1551 34940997
Hypertriglyceridaemia 426.51 22.62 152 14231 8296 34934252
Febrile bone marrow aplasia 423.15 22.62 150 14233 8059 34934489
Hyperbilirubinaemia 303.52 22.62 145 14238 16698 34925850
Mucosal inflammation 165.94 22.62 133 14250 38489 34904059
Pancreatitis 152.51 22.62 127 14256 38764 34903784
Venoocclusive liver disease 132.58 22.62 65 14318 7901 34934647
Neutropenia 122.77 22.62 226 14157 156552 34785996
Anaphylactic reaction 117.40 22.62 101 14282 32200 34910348
Death 116.13 22.62 14 14369 398035 34544513
Vomiting 95.03 22.62 269 14114 247352 34695196
Blood fibrinogen decreased 88.94 22.62 29 14354 1201 34941347
Abdominal pain 86.81 22.62 201 14182 163417 34779131
Coagulopathy 84.59 22.62 68 14315 19721 34922827
Hepatotoxicity 75.64 22.62 66 14317 21419 34921129
Pancreatitis acute 74.98 22.62 74 14309 28067 34914481
Cerebral venous sinus thrombosis 74.72 22.62 21 14362 520 34942028
Posterior reversible encephalopathy syndrome 74.31 22.62 48 14335 9906 34932642
Gallbladder oedema 70.49 22.62 17 14366 225 34942323
Blood bilirubin increased 69.16 22.62 82 14301 38214 34904334
Lentigo 67.06 22.62 19 14364 485 34942063
Hepatic steatosis 63.81 22.62 56 14327 18306 34924242
Hepatocellular injury 62.14 22.62 60 14323 22151 34920397
Cerebral thrombosis 61.91 22.62 21 14362 984 34941564
Sepsis 61.82 22.62 179 14204 166382 34776166
Leukoencephalopathy 60.15 22.62 31 14352 4184 34938364
Colitis 58.75 22.62 75 14308 37675 34904873
Potentiating drug interaction 58.05 22.62 32 14351 4945 34937603
Cholestasis 55.90 22.62 62 14321 26886 34915662
Tachycardia 54.92 22.62 113 14270 84659 34857889
Hyperglycaemia 54.57 22.62 74 14309 39406 34903142
Superior sagittal sinus thrombosis 53.62 22.62 14 14369 260 34942288
Ascites 52.19 22.62 79 14304 46492 34896056
Alanine aminotransferase increased 51.50 22.62 107 14276 80708 34861840
Cerebral venous thrombosis 51.38 22.62 17 14366 737 34941811
Septic shock 49.19 22.62 98 14285 71736 34870812
Bone marrow failure 48.50 22.62 60 14323 29193 34913355
Blood culture positive 48.34 22.62 28 14355 4755 34937793
Myelosuppression 48.24 22.62 49 14334 19216 34923332
Bacteraemia 47.29 22.62 49 14334 19668 34922880
Antithrombin III decreased 46.29 22.62 13 14370 321 34942227
Drug ineffective 45.42 22.62 74 14309 456677 34485871
Pyrexia 45.41 22.62 262 14121 332751 34609797
Fungal infection 44.48 22.62 43 14340 15892 34926656
Oesophageal stenosis 44.13 22.62 19 14364 1711 34940837
Hepatomegaly 42.88 22.62 35 14348 10361 34932187
Acute lymphocytic leukaemia recurrent 42.32 22.62 22 14361 3022 34939526
Gastrointestinal wall thickening 40.02 22.62 17 14366 1481 34941067
Lipase increased 39.47 22.62 32 14351 9384 34933164
Escherichia infection 38.81 22.62 30 14353 8215 34934333
Neurotoxicity 38.31 22.62 42 14341 17968 34924580
Product dose omission issue 37.93 22.62 3 14380 119708 34822840
Pseudomonas test positive 37.59 22.62 15 14368 1114 34941434
Steatohepatitis 37.42 22.62 11 14372 321 34942227
Fatigue 35.90 22.62 61 14322 370592 34571956
Mucormycosis 35.59 22.62 25 14358 5917 34936631
Periorbital infection 35.50 22.62 9 14374 148 34942400
Escherichia bacteraemia 35.28 22.62 20 14363 3260 34939288
Intussusception 33.99 22.62 12 14371 634 34941914
Antithrombin III deficiency 33.52 22.62 8 14375 101 34942447
Thrombocytopenia 33.45 22.62 140 14243 156107 34786441
Atypical haemolytic uraemic syndrome 33.28 22.62 10 14373 315 34942233
Respiratory distress 32.40 22.62 55 14328 35610 34906938
Aspergillus infection 32.20 22.62 32 14351 12222 34930326
Escherichia sepsis 31.02 22.62 21 14362 4683 34937865
Candida infection 30.43 22.62 37 14346 17678 34924870
Parainfluenzae virus infection 29.75 22.62 17 14366 2813 34939735
Dyspnoea 29.62 22.62 70 14313 376712 34565836
Hypoalbuminaemia 28.73 22.62 30 14353 12144 34930404
Vascular access complication 28.54 22.62 9 14374 334 34942214
Mixed anxiety and depressive disorder 28.40 22.62 7 14376 102 34942446
Neutropenic colitis 28.09 22.62 17 14366 3127 34939421
Mucosal infection 27.56 22.62 8 14375 223 34942325
Osteonecrosis 27.05 22.62 32 14351 14858 34927690
Depression 26.79 22.62 4 14379 97094 34845454
Condition aggravated 26.57 22.62 24 14359 192172 34750376
Cytomegalovirus hepatitis 25.89 22.62 9 14374 454 34942094
Gamma-glutamyltransferase increased 25.13 22.62 44 14339 29187 34913361
Insomnia 25.02 22.62 6 14377 103901 34838647
Pancytopenia 25.00 22.62 91 14292 95066 34847482
Overdose 24.56 22.62 4 14379 91055 34851493
Prothrombin level abnormal 24.43 22.62 6 14377 86 34942462
Stomatitis 24.41 22.62 54 14329 42460 34900088
Multiple lentigines syndrome 24.12 22.62 5 14378 31 34942517
Clostridium difficile colitis 24.05 22.62 31 14352 15699 34926849
Hypersensitivity 23.92 22.62 67 14316 60968 34881580
Haemophagocytic lymphohistiocytosis 23.76 22.62 28 14355 12945 34929603
Acral lentiginous melanoma 23.73 22.62 5 14378 34 34942514
Lewis-Sumner syndrome 23.73 22.62 5 14378 34 34942514
Enterocolitis infectious 22.85 22.62 12 14371 1683 34940865
Meningitis bacterial 22.74 22.62 11 14372 1296 34941252
Optic nerve disorder 22.62 22.62 9 14374 663 34941885

FDA Adverse Event Reporting System (Geriatric)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Febrile neutropenia 1763.92 23.07 1003 22951 229996 79490438
Febrile bone marrow aplasia 655.33 23.07 216 23738 12804 79707630
Hypertriglyceridaemia 595.89 23.07 200 23754 12540 79707894
Hypofibrinogenaemia 527.04 23.07 122 23832 1880 79718554
Hyperbilirubinaemia 306.86 23.07 149 23805 24369 79696065
Secondary immunodeficiency 300.69 23.07 86 23868 3148 79717286
Bacterial infection 261.57 23.07 145 23809 31135 79689299
Neutropenia 243.10 23.07 361 23593 287349 79433085
Pancreatitis 242.26 23.07 185 23769 68390 79652044
Mucosal inflammation 234.82 23.07 189 23765 75391 79645043
Mycobacterium chelonae infection 182.93 23.07 55 23899 2401 79718033
Pseudomonal sepsis 182.48 23.07 69 23885 6105 79714329
Blood culture positive 181.78 23.07 75 23879 8354 79712080
Rhinovirus infection 165.55 23.07 69 23885 7884 79712550
Human bocavirus infection 162.52 23.07 39 23915 706 79719728
Posterior reversible encephalopathy syndrome 161.97 23.07 100 23854 26181 79694253
Superior sagittal sinus thrombosis 153.57 23.07 40 23914 1023 79719411
Clostridium difficile colitis 150.26 23.07 103 23851 32180 79688254
Sepsis 144.33 23.07 276 23678 269152 79451282
Parainfluenzae virus infection 141.25 23.07 56 23898 5626 79714808
Venoocclusive liver disease 133.72 23.07 67 23887 11704 79708730
Pyrexia 130.48 23.07 473 23481 678236 79042198
Colitis 126.66 23.07 132 23822 73175 79647259
Blood fibrinogen decreased 124.79 23.07 39 23915 1940 79718494
Anaphylactic reaction 118.93 23.07 136 23818 83607 79636827
Thymus hypoplasia 118.58 23.07 32 23922 941 79719493
Septic shock 116.42 23.07 163 23791 122638 79597796
Pancreatitis acute 111.20 23.07 103 23851 49501 79670933
Enterobacter infection 110.05 23.07 44 23910 4518 79715916
Hyperglycaemia 109.76 23.07 120 23834 70215 79650219
Drug ineffective 109.18 23.07 99 23855 1080814 78639620
Mucormycosis 107.51 23.07 52 23902 8417 79712017
Coagulopathy 107.42 23.07 88 23866 35918 79684516
Lymphoid tissue hypoplasia 105.93 23.07 29 23925 901 79719533
Cystitis bacterial 103.94 23.07 27 23927 683 79719751
Viral infection 103.61 23.07 93 23861 42923 79677511
Norovirus test positive 100.92 23.07 26 23928 636 79719798
Aspergillus infection 100.84 23.07 66 23888 19095 79701339
Human herpesvirus 6 infection 99.82 23.07 43 23911 5327 79715107
Lipase increased 99.78 23.07 62 23892 16404 79704030
Pneumatosis intestinalis 95.73 23.07 44 23910 6353 79714081
Bacteraemia 93.28 23.07 78 23876 32746 79687688
Blood bilirubin increased 93.07 23.07 107 23847 66125 79654309
Pseudomonas test positive 90.20 23.07 30 23924 1822 79718612
Bone marrow failure 90.01 23.07 93 23861 51014 79669420
Hepatotoxicity 89.63 23.07 93 23861 51259 79669175
Cerebral venous sinus thrombosis 87.75 23.07 31 23923 2260 79718174
Fungal infection 84.62 23.07 82 23872 41666 79678768
Fatigue 83.64 23.07 94 23860 929633 78790801
Antithrombin III decreased 82.91 23.07 21 23933 479 79719955
Tachycardia 81.71 23.07 171 23783 177597 79542837
Thrombocytopenia 81.49 23.07 218 23736 265041 79455393
Abscess bacterial 81.22 23.07 23 23931 811 79719623
Acute lymphocytic leukaemia recurrent 78.63 23.07 35 23919 4689 79715745
Intracardiac thrombus 78.56 23.07 34 23920 4259 79716175
Neurotoxicity 73.79 23.07 68 23886 32450 79687984
Pancytopenia 73.34 23.07 157 23797 165588 79554846
Lentigo 73.09 23.07 19 23935 482 79719952
Myelosuppression 72.16 23.07 74 23880 40222 79680212
Cholestasis 71.21 23.07 83 23871 52026 79668408
Hepatocellular injury 70.43 23.07 79 23875 47514 79672920
Bronchopulmonary aspergillosis 69.68 23.07 56 23898 22238 79698196
Perineal necrosis 67.86 23.07 14 23940 121 79720313
Leukoencephalopathy 66.90 23.07 37 23917 7892 79712542
Alanine aminotransferase increased 66.26 23.07 149 23805 162421 79558013
Pyomyositis 64.33 23.07 18 23936 607 79719827
Hypoalbuminaemia 63.40 23.07 52 23902 21245 79699189
Device related infection 63.26 23.07 64 23890 34230 79686204
Abdominal pain 61.83 23.07 256 23698 389313 79331121
Drug intolerance 60.63 23.07 5 23949 264114 79456320
Hepatomegaly 60.24 23.07 48 23906 18826 79701608
Fall 60.21 23.07 36 23918 487593 79232841
Viraemia 60.06 23.07 25 23929 2844 79717590
Hypotension 59.72 23.07 276 23678 440041 79280393
Clostridium test positive 59.68 23.07 32 23922 6422 79714012
Enteritis 59.63 23.07 43 23911 14540 79705894
Oesophageal candidiasis 59.13 23.07 36 23918 9182 79711252
Condition aggravated 59.12 23.07 39 23915 501085 79219349
Seizure 57.74 23.07 155 23799 188679 79531755
Vomiting 57.60 23.07 369 23585 665459 79054975
Neutrophil count decreased 56.11 23.07 101 23853 93858 79626576
Ascites 55.40 23.07 89 23865 75473 79644961
Cerebral venous thrombosis 54.32 23.07 23 23931 2730 79717704
Cytomegalovirus chorioretinitis 52.96 23.07 28 23926 5462 79714972
Potentiating drug interaction 52.90 23.07 33 23921 8786 79711648
Coronavirus infection 52.56 23.07 31 23923 7466 79712968
Diffuse alveolar damage 51.46 23.07 24 23930 3580 79716854
Pain 51.16 23.07 83 23871 703719 79016715
Arthralgia 51.06 23.07 58 23896 571745 79148689
Nasopharyngitis 50.32 23.07 8 23946 253873 79466561
Human rhinovirus test positive 49.95 23.07 14 23940 475 79719959
Hepatic steatosis 49.71 23.07 59 23895 37679 79682755
Blood lactic acid increased 48.53 23.07 36 23918 12708 79707726
Escherichia bacteraemia 48.29 23.07 28 23926 6534 79713900
Atrial fibrillation 47.55 23.07 3 23951 197883 79522551
Candida infection 47.48 23.07 58 23896 38156 79682278
Malaise 46.72 23.07 47 23907 489822 79230612
Neutropenic colitis 46.42 23.07 26 23928 5681 79714753
Disseminated aspergillosis 46.16 23.07 16 23938 1102 79719332
Cytomegalovirus viraemia 46.12 23.07 35 23919 12786 79707648
Death 45.82 23.07 62 23892 566452 79153982
Staphylococcal bacteraemia 45.38 23.07 34 23920 12184 79708250
Fusarium infection 45.33 23.07 18 23936 1814 79718620
Mucosal infection 44.67 23.07 13 23941 506 79719928
Peripheral swelling 44.30 23.07 13 23941 269604 79450830
Enterovirus infection 44.27 23.07 18 23936 1929 79718505
Oesophageal stenosis 44.26 23.07 23 23931 4331 79716103
Cerebral thrombosis 43.99 23.07 19 23935 2368 79718066
Dyspnoea 43.97 23.07 123 23831 856902 78863532
Aplasia 43.75 23.07 28 23926 7792 79712642
Overdose 43.65 23.07 3 23951 184203 79536231
Perineal infection 43.03 23.07 14 23940 793 79719641
Gastroenteritis norovirus 42.24 23.07 20 23934 3086 79717348
Urinary tract infection 41.99 23.07 15 23939 274497 79445937
Respiratory distress 41.78 23.07 68 23886 58271 79662163
Hyperammonaemia 41.49 23.07 31 23923 11062 79709372
Venous thrombosis 41.11 23.07 26 23928 7090 79713344
Hepatic failure 39.37 23.07 68 23886 61144 79659290
Pneumonia fungal 39.00 23.07 30 23924 11180 79709254
Bacillus test positive 38.96 23.07 9 23945 137 79720297
Escherichia test positive 38.81 23.07 19 23935 3156 79717278
Tachypnoea 38.76 23.07 48 23906 32015 79688419
Myocardial infarction 38.35 23.07 5 23949 184124 79536310
Enterocolitis 38.18 23.07 33 23921 14479 79705955
Intussusception 37.94 23.07 14 23940 1156 79719278
Therapeutic product effect decreased 37.87 23.07 3 23951 163860 79556574
Abdominal discomfort 37.84 23.07 14 23940 250713 79469721
Escherichia infection 37.65 23.07 36 23918 17981 79702453
Transverse sinus thrombosis 37.35 23.07 12 23942 653 79719781
Multiple organ dysfunction syndrome 37.02 23.07 99 23855 120147 79600287
Osteonecrosis 36.71 23.07 46 23908 31049 79689385
Platelet count decreased 36.55 23.07 135 23819 194529 79525905
Insomnia 36.48 23.07 14 23940 245156 79475278
Enterococcus test positive 36.34 23.07 16 23938 2088 79718346
Muscle spasms 35.78 23.07 5 23949 174725 79545709
Dizziness 35.53 23.07 65 23889 526376 79194058
Streptococcus test positive 35.39 23.07 16 23938 2222 79718212
Haemophagocytic lymphohistiocytosis 35.33 23.07 38 23916 21799 79698635
Pancreatitis necrotising 35.08 23.07 19 23935 3889 79716545
Fungaemia 34.87 23.07 20 23934 4571 79715863
Enterocolitis infectious 34.56 23.07 17 23937 2852 79717582
Brain oedema 34.10 23.07 40 23914 25223 79695211
Pulmonary haemorrhage 33.81 23.07 31 23923 14686 79705748
Pleural effusion 32.70 23.07 107 23847 145155 79575279
Hypophagia 32.64 23.07 53 23901 45314 79675120
Herpes simplex 32.64 23.07 28 23926 12159 79708275
Neuropathy peripheral 32.63 23.07 105 23849 141200 79579234
Escherichia sepsis 32.32 23.07 24 23930 8484 79711950
Drug interaction 31.98 23.07 47 23907 415136 79305298
Renal replacement therapy 31.94 23.07 8 23946 174 79720260
Hyperglycaemic hyperosmolar nonketotic syndrome 31.84 23.07 15 23939 2288 79718146
Disseminated intravascular coagulation 31.59 23.07 46 23908 35796 79684638
Depression 31.23 23.07 13 23941 216777 79503657
Pruritus 31.05 23.07 44 23910 394604 79325830
Systemic candida 30.25 23.07 21 23933 6685 79713749
Oral herpes 29.86 23.07 39 23915 27415 79693019
Antithrombin III deficiency 29.69 23.07 7 23947 117 79720317
Intentional product use issue 29.66 23.07 5 23949 152107 79568327
Tumour lysis syndrome 29.19 23.07 36 23918 23903 79696531
Gamma-glutamyltransferase increased 29.14 23.07 56 23898 54624 79665810
Steatohepatitis 29.02 23.07 11 23943 979 79719455
Hypoxia 28.80 23.07 82 23872 103161 79617273
Rhinocerebral mucormycosis 28.31 23.07 11 23943 1047 79719387
Respiratory failure 27.92 23.07 118 23836 180793 79539641
Stomatococcal infection 27.85 23.07 8 23946 297 79720137
Musculoskeletal stiffness 27.73 23.07 9 23945 174999 79545435
Apnoea 27.57 23.07 25 23929 11679 79708755
Perirectal abscess 27.32 23.07 13 23941 2028 79718406
Soft tissue infection 26.96 23.07 16 23938 3896 79716538
Respiratory syncytial virus test positive 26.79 23.07 8 23946 341 79720093
Pulse absent 26.63 23.07 23 23931 10080 79710354
Vascular access complication 26.50 23.07 13 23941 2169 79718265
Peripheral motor neuropathy 26.47 23.07 15 23939 3352 79717082
Antithrombin III 26.25 23.07 6 23948 87 79720347
Stomatitis 26.06 23.07 100 23854 146657 79573777
Hypogonadism 26.00 23.07 12 23942 1748 79718686
Weight increased 25.96 23.07 27 23927 277359 79443075
Anorectal cellulitis 25.93 23.07 6 23948 92 79720342
Intracranial hypotension 25.40 23.07 8 23946 408 79720026
Cholangitis infective 25.32 23.07 9 23945 668 79719766
Atypical haemolytic uraemic syndrome 25.05 23.07 10 23944 1022 79719412
Diarrhoea 24.81 23.07 159 23795 880330 78840104
Mental status changes 24.64 23.07 59 23895 66900 79653534
Lewis-Sumner syndrome 24.58 23.07 5 23949 40 79720394
Wound 24.56 23.07 3 23951 116176 79604258
Cellulitis 24.23 23.07 80 23874 108980 79611454
Coronavirus test positive 24.18 23.07 10 23944 1119 79719315
Cytomegalovirus hepatitis 24.03 23.07 9 23945 775 79719659
Pulmonary mucormycosis 23.88 23.07 10 23944 1155 79719279
Product use issue 23.80 23.07 17 23937 209805 79510629
Acral lentiginous melanoma 23.67 23.07 5 23949 49 79720385
Unresponsive to stimuli 23.67 23.07 52 23902 55736 79664698
Interstitial lung disease 23.58 23.07 3 23951 112597 79607837
Leukaemic infiltration 23.48 23.07 6 23948 142 79720292
Enterovirus test positive 23.45 23.07 7 23947 298 79720136
Rash 23.39 23.07 92 23862 578266 79142168
Quadriparesis 23.30 23.07 14 23940 3487 79716947

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

SourceCodeDescription
ATC L01XX24 ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
ANTINEOPLASTIC AGENTS
OTHER ANTINEOPLASTIC AGENTS
Other antineoplastic agents
FDA CS M0001815 Asparaginase
MeSH PA D000970 Antineoplastic Agents
FDA EPC N0000175669 Asparagine-specific Enzyme

Drug Use | Suggest Off label Use Form| |View source of the data|

DiseaseRelationSNOMED_IDDOID
Acute lymphoid leukemia indication 91857003 DOID:9952




🐶 Veterinary Drug Use

None

🐶 Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

None

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

None

External reference:

IDSource
7D96IR0PPM UNII
D05387 KEGG_DRUG
4020867 VANDF
C0071568 UMLSCUI
CHEMBL2108546 ChEMBL_ID
436058 PUBCHEM_CID
DB00059 DRUGBANK_ID
6665 INN_ID
C042705 MESH_SUPPLEMENTAL_RECORD_UI
224911 RXNORM
11316 MMSL
5239 MMSL
d04247 MMSL
004476 NDDF
108814000 SNOMEDCT_US
416337002 SNOMEDCT_US

Pharmaceutical products:

ProductCategoryIngredientsNDCFormQuantityRouteMarketingLabel
LYOPHILIZED PEGASPARGASE HUMAN PRESCRIPTION DRUG LABEL 1 72694-313 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION 750 [iU] INTRAVENOUS EXPORT ONLY 1 sections
ONCASPAR HUMAN PRESCRIPTION DRUG LABEL 1 72694-954 INJECTION, SOLUTION 750 [iU] INTRAVENOUS BLA 31 sections
ONCASPAR HUMAN PRESCRIPTION DRUG LABEL 1 72694-954 INJECTION, SOLUTION 750 [iU] INTRAVENOUS BLA 31 sections
ONCASPAR HUMAN PRESCRIPTION DRUG LABEL 1 72694-954 INJECTION, SOLUTION 750 [iU] INTRAVENOUS BLA 31 sections